HLA class I supertypes: a revised and updated classification
Open accessThe DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Background: Class I major histocompatibility complex (MHC) molecules bind, and present to T cells, short peptides derived from intracellular processing of proteins. The peptide repertoire of a specific molecule is to a large extent determined by the molecular structure accommodating so-called main anchor positions of the presented peptide. These receptors are extremely polymorphic, and much of the polymorphism influences the peptide-binding repertoire. However, despite this polymorphism, class I molecules can be clustered into sets of molecules that bind largely overlapping peptide repertoires. Almost a decade ago we introduced this concept of clustering human leukocyte antigen (HLA) alleles and defined nine different groups, denominated as supertypes, on the basis of their main anchor specificity. The utility of this original supertype classification, as well several other subsequent arrangements derived by others, has been demonstrated in a large number of epitope identification studies. Results: Following our original approach, in the present report we provide an updated classification of HLA-A and -B class I alleles into supertypes. The present analysis incorporates the large amount of class I MHC binding data and sequence information that has become available in the last decade. As a result, over 80% of the 945 different HLA-A and -B alleles examined to date can be assigned to one of the original nine supertypes. A few alleles are expected to be associated with repertoires that overlap multiple supertypes. Interestingly, the current analysis did not identify any additional supertype specificities. Conclusion: As a result of this updated analysis, HLA supertype associations have been defined for over 750 different HLA-A and -B alleles. This information is expected to facilitate epitope identification and vaccine design studies, as well as investigations into disease association and correlates of immunity. In addition, the approach utilized has been made more transparent, allowing others to utilize the classification approach going forward.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These supertypes together cover most HLA-A and HLA-B alleles found in distinct populations (52, 53).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [53]
Experimental — accuracy not yet measuredIn the citing paper
“Individual HLA-I alleles are classified into 12 discrete supertypes (52, 53), on the basis of similar peptide-anchor–binding specificities (26, 52, 53).”
From Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2018) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H.-G. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,411
Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., & Wiley, D. C. (1987) · Nature · doi:10.1038/329512a0 · Cited by 2,377
SYFPEITHI: database for MHC ligands and peptide motifs
Rammensee, H. G., Bachmann, J., Emmerich, N. P. N., Bachor, O. A., & Stevanović, S. (1999) · Immunogenetics · doi:10.1007/s002510050595 · Cited by 2,314
Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution
Saper, M. A., Bjorkman, P. J., & Wiley, D. C. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90567-p · Cited by 1,077
The Three-Dimensional Structure of Peptide-MHC Complexes
Madden, D. R. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.587 · Cited by 842
IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex
Robinson, J. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg070 · Cited by 810
Madden, D. (1993) · Cell · doi:10.1016/0092-8674(93)90490-h · Cited by 675
Madden, D. R., Gorga, J. C., Strominger, J. L., & Wiley, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90252-8 · Cited by 656
Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
Sette, A., & Sidney, J. (1999) · Immunogenetics · doi:10.1007/s002510050594 · Cited by 635
Self-citationDifferent length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle
Guo, H.-C., Jardetzky, T. S., Garrettt, T. P. J., Lane, W. S., Strominger, J. L., & Wiley, D. C. (1992) · Nature · doi:10.1038/360364a0 · Cited by 404
The Immune Epitope Database and Analysis Resource: From Vision to Blueprint
Peters, B., Sidney, J., Bourne, P., Bui, H.-H., Buus, S., Doh, G., Fleri, W., Kronenberg, M., Kubo, R., Lund, O., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030091 · Cited by 373
Self-citationTenzer, S., Peters, B., Bulik, S., Schoor, O., Lemmel, C., Schatz, M. M., Kloetzel, P.-M., Rammensee, H.-G., Schild, H., & Holzhütter, H.-G. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4528-2 · Cited by 349
Self-citationAdvantage of rare HLA supertype in HIV disease progression
Trachtenberg, E., Korber, B., Sollars, C., Kepler, T. B., Hraber, P. T., Hayes, E., Funkhouser, R., Fugate, M., Theiler, J., Hsu, Y. S., et al. (2003) · Nature Medicine · doi:10.1038/nm893 · Cited by 348
Definition of supertypes for HLA molecules using clustering of specificity matrices
Lund, O., Nielsen, M., Kesmir, C., Petersen, A. G., R�der, G., Justesen, S., Lundegaard, C., Worning, P., Sylvester-Hvid, C., Lamberth, K., et al. (2004) · Immunogenetics · doi:10.1007/s00251-004-0647-4 · Cited by 292
MacDonald, K. S., Fowke, K. R., Kimani, J., Dunand, V. A., Nagelkerke, N. J. D., Ball, T. B., Oyugi, J., Njagi, E., Gaur, L. K., Brunham, R. C., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315472 · Cited by 269
Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs
Sidney, J., Grey, H. M., Kubo, R. T., & Sette, A. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80542-1 · Cited by 260
Self-citationFremont, D. H., Stura, E. A., Matsumura, M., Peterson, P. A., & Wilson, I. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2479 · Cited by 256
Atomic structure of a human MHC molecule presenting an influenza virus peptide
Silver, M. L., Guo, H.-C., Strominger, J. L., & Wiley, D. C. (1992) · Nature · doi:10.1038/360367a0 · Cited by 251
HLA supertypes and supermotifs: a functional perspective on HLA polymorphism
Sette, A., & Sidney, J. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80124-6 · Cited by 243
Self-citationIdentification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data
Doolan, D. L., Southwood, S., Freilich, D. A., Sidney, J., Graber, N. L., Shatney, L., Bebris, L., Florens, L., Dobano, C., Witney, A. A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633254100 · Cited by 237
Self-citationKawashima, I., Hudson, S. J., Tsai, V., Southwood, S., Takesako, K., Appella, E., Sette, A., & Celis, E. (1998) · Human Immunology · doi:10.1016/s0198-8859(97)00255-3 · Cited by 229
Self-citationBinding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype.
del Guercio, M. F., Sidney, J., Hermanson, G., Perez, C., Grey, H. M., Kubo, R. T., & Sette, A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.2.685 · Cited by 205
Self-citationMacdonald, W. A., Purcell, A. W., Mifsud, N. A., Ely, L. K., Williams, D. S., Chang, L., Gorman, J. J., Clements, C. S., Kjer-Nielsen, L., Koelle, D. M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030066 · Cited by 204
MHCBN: a comprehensive database of MHC binding and non-binding peptides
Bhasin, M., Singh, H., & Raghava, G. P. S. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg055 · Cited by 201
Sidney, J., Grey, H. M., Southwood, S., Celis, E., Wentworth, P. A., del Guercio, M.-F., Kubo, R. T., Chesnut, R. W., & Sette, A. (1996) · Human Immunology · doi:10.1016/0198-8859(95)00173-5 · Cited by 195
Self-citationSeveral HLA alleles share overlapping peptide specificities.
Sidney, J., del Guercio, M. F., Southwood, S., Engelhard, V. H., Appella, E., Rammensee, H. G., Falk, K., Rötzschke, O., Takiguchi, M., Kubo, R. T., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.247 · Cited by 194
Self-citationAssarsson, E., Sidney, J., Oseroff, C., Pasquetto, V., Bui, H.-H., Frahm, N., Brander, C., Peters, B., Grey, H., & Sette, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7890 · Cited by 191
Self-citationDoolan, D. L., Hoffman, S. L., Southwood, S., Wentworth, P. A., Sidney, J., Chesnut, R. W., Keogh, E., Appella, E., Nutman, T. B., Lal, A. A., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80513-0 · Cited by 187
Self-citationPérarnau, B., Saron, M.-F., San Martin, B. R., Bervas, N., Ong, H., Soloski, M. J., Smith, A. G., Ure, J. M., Gairin, J. E., & Lemonnier, F. A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199904)29:04<1243::aid-immu1243>3.0.co;2-a · Cited by 186
Khanna, R., Burrows, S. R., Nicholls, J., & Poulsen, L. M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199802)28:02<451::aid-immu451>3.0.co;2-u · Cited by 178
Bertoni, R., Sidney, J., Fowler, P., Chesnut, R. W., Chisari, F. V., & Sette, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119559 · Cited by 162
Self-citationOseroff, C., Kos, F. J., Bui, H., Peters, B., Pasquetto, V., Glenn, J., Palmore, T. N., Sidney, J., Tscharke, D. C., Bennink, J. R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506768102 · Cited by 160
Self-citationNovitsky, V., Gilbert, P. B., Peter, T., McLane, M. F., Gaolekwe, S., Rybak, N., Thior, I., Ndung’u, T., Marlink, R., Lee, T. H., et al. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.882-890.2003 · Cited by 158
Bihl, F., Frahm, N., Di Giammarino, L., Sidney, J., John, M., Yusim, K., Woodberry, T., Sango, K., Hewitt, H. S., Henry, L., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4094 · Cited by 157
Self-citationMULTIPRED: a computational system for prediction of promiscuous HLA binding peptides
Zhang, G. L., Khan, A. M., Srinivasan, K. N., August, J. T., & Brusić, V. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki452 · Cited by 141
Extensive HLA class I allele promiscuity among viral CTL epitopes
Frahm, N., Yusim, K., Suscovich, T. J., Adams, S. D., Sidney, J., Hraber, P., Hewitt, H. S., Linde, C., Kavanagh, D. G., Woodberry, T., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200737365 · Cited by 140
Self-citationKeogh, E., Fikes, J., Southwood, S., Celis, E., Chesnut, R., & Sette, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.787 · Cited by 133
Self-citationA roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities
Chelvanayagam, G. (1996) · Immunogenetics · doi:10.1007/s002510050162 · Cited by 130
Structural principles that govern the peptide-binding motifs of class I MHC molecules
Zhang, C., Anderson, A., & DeLisi, C. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1982 · Cited by 127
Kawashima, I., Tsai, V., Southwood, S., Takesako, K., Sette, A., & Celis, E. (1999) · PubMed · Cited by 127
Self-citationIdentifiying Human MHC Supertypes Using Bioinformatic Methods
Doytchinova, I. A., Guan, P., & Flower, D. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4314 · Cited by 126
Pasquetto, V., Bui, H., Giannino, R., Mirza, F., Sidney, J., Oseroff, C., Tscharke, D. C., Irvine, K. R., Bennink, J. R., Peters, B., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5504 · Cited by 124
Self-citationSidney, J., Southwood, S., Mann, D. L., Fernández-Viña, M., Newman, M. J., & Sette, A. (2001) · Human Immunology · doi:10.1016/s0198-8859(01)00319-6 · Cited by 122
Self-citationReche, P. A., & Reinherz, E. L. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki357 · Cited by 117
Chang, K., Gruener, N. H., Southwood, S., Sidney, J., Pape, G. R., Chisari, F. V., & Sette, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.1156 · Cited by 116
Self-citationWang, R., Johnston, S. L., Southwood, S., Sette, A., & Rosenberg, S. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.890 · Cited by 105
Self-citationSpecificity and degeneracy in peptide binding to HLA-B7-like class I molecules
Sidney, J., Southwood, S., del Guercio, M. F., Grey, H. M., Chesnut, R. W., Kubo, R. T., & Sette, A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3480 · Cited by 104
Self-citationWilson, C. C., McKinney, D. M., Anders, M., MaWhinney, S., Forster, J. E., Crimi, C., Southwood, S., Sette, A., Chesnut, R. W., Newman, M. J., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5611 · Cited by 103
Self-citationMata, M., Travers, P. J., Liu, Q., Frankel, F. R., & Paterson, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2985 · Cited by 102
Threlkeld, S. C., Wentworth, P. A., Kalams, S. A., Wilkes, B. M., Ruhl, D. J., Keogh, E., Sidney, J., Southwood, S., Walker, B. D., & Sette, A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.4.1648 · Cited by 100
Self-citationPrediction of promiscuous peptides that bind HLA class I molecules
Brusić, V., Petrovsky, N., Zhang, G., & Bajić, V. B. (2002) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2002.01088.x · Cited by 99
Stoesser, G., Griffith, M., & Griffith, O. L. (2004) · Wiley eBooks · doi:10.1002/9780471650126.dob0322.pub2 · Cited by 97
HIV-1 diversity versus HLA class I polymorphism
Stephens, H. A. F. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.11.001 · Cited by 94
Association of ankylosing spondylitis with HLA–B*1403 in a West African population
López‐Larrea, C., Mijiyawa, M., Gonzalez, S. R., Fernández-Morera, J. L., Blanco-Gelaz, M. Á., Martínez-Borra, J., & López‐Vázquez, A. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10584 · Cited by 94
Altfeld, M. A., Livingston, B. D., Reshamwala, N., Nguyen, P., Addo, M. M., Shea, A. K., Newman, M. J., Fikes, J. D., Sidney, J., Wentworth, P. A., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1301-1311.2001 · Cited by 93
Self-citationA systematic bioinformatics approach for selection of epitope-based vaccine targets
Khan, A. M., Miotto, O., Heiny, A. T., Salmon, J., Srinivasan, K. N., Nascimento, E. J. M., Marques, E. T. A., Brusić, V., Tan, T. W., & August, J. T. (2006) · Cellular Immunology · doi:10.1016/j.cellimm.2007.02.005 · Cited by 90
Leslie, A. J., Price, D. A., Mkhize, P. P., Bishop, K., Rathod, A., Day, C. L., Crawford, H., Honeyborne, I., Asher, T. E., Luzzi, G. A., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4699 · Cited by 89
Self-citationMacDonald, K. S., Embree, J. E., Nagelkerke, N. J. D., Castillo, J., Ramhadin, S., Njenga, S., Oyug, J., Ndinya‐Achola, J. O., Barber, B. H., Bwayo, J. J., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/318092 · Cited by 88
López‐Vázquez, A., Miña‐Blanco, A., Martı́nez-Borra, J., Njobvu, P., Suárez-Álvarez, B., Blanco-Gelaz, M. Á., Gonzalez, S. R., Rodrigo, L., & López‐Larrea, C. (2005) · Human Immunology · doi:10.1016/j.humimm.2005.01.001 · Cited by 87
Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS
Scherer, A., Frater, J., Oxenius, A., Agudelo, J., Price, D. A., Günthard, H. F., Barnardo, M., Perrin, L. H., Hirschel, B. J., Phillips, R. E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404091101 · Cited by 85
McMurry, J. A., Gregory, S. H., Moise, L., Rivera, D. S., Buus, S., & Groot, A. S. D. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.039 · Cited by 78
Li, H., Natarajan, K., Malchiodi, E. L., Margulies, D. H., & Mariuzza, R. A. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2091 · Cited by 76
Ovsyannikova, I. G., Jacobson, R. M., Vierkant, R. A., Pankratz, V. S., & Poland, G. A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.020 · Cited by 70
Peptide motifs of HLA-B58, B60, B61, and B62 molecules
Falk, K., Rötzschke, O., Takiguchi, M., Gnau, V., Stevanović, S., Jung, G., & Rammensee, H. (1995) · Immunogenetics · doi:10.1007/bf00182333 · Cited by 69
Apostolopoulos, V., Yu, M., Corper, A. L., Teyton, L., Pietersz, G. A., McKenzie, I. F. C., Wilson, I. A., & Plebanski, M. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00196-1 · Cited by 69
Wentworth, P. A., Sette, A., Celis, E., Sidney, J., Southwood, S., Crimi, C., Stitely, S., Keogh, E. A., Wong, N. C., Livingston, B. D., et al. (1996) · International Immunology · doi:10.1093/intimm/8.5.651 · Cited by 69
Self-citationFIMM, a database of functional molecular immunology
Schönbach, C., Koh, J. L., Sheng, X., Wong, L., & Brusic, V. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.222 · Cited by 68
Identification of Protective Lassa Virus Epitopes That Are Restricted by HLA-A2
Botten, J., Alexander, J., Pasquetto, V., Sidney, J., Barrowman, P., Ting, J. P., Peters, B., Southwood, S., Stewart, B. S., Rodriguez‐Carreno, M. P., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00896-06 · Cited by 65
Self-citationDefinition of MHC Supertypes Through Clustering of MHC Peptide-Binding Repertoires
Reche, P. A., & Reinherz, E. L. (2007) · Methods in molecular biology · doi:10.1007/978-1-60327-118-9_11 · Cited by 64
In silicogrouping of peptide/HLA class I complexes using structural interaction characteristics
Tong, J. C., Tan, T. W., & Ranganathan, S. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl563 · Cited by 64
Integrating epitope data into the emerging web of biomedical knowledge resources
Peters, B., & Sette, A. (2007) · Nature reviews. Immunology · doi:10.1038/nri2092 · Cited by 63
Self-citationHaskó, G., Szabó, C., Németh, Z. H., Salzman, A. L., & Vizi, E. S. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199802)28:02<468::aid-immu468>3.0.co;2-z · Cited by 62
SARS CTL vaccine candidates; HLA supertype‐, genome‐wide scanning and biochemical validation
Sylvester‐Hvid, C., Nielsen, M., Lamberth, K., Røder, G., Justesen, S. F. L., Lundegaard, C., Worning, P., Thomadsen, H., Lund, O., Brunak, S., et al. (2004) · Tissue Antigens · doi:10.1111/j.0001-2815.2004.00221.x · Cited by 62
HLA-B15 Peptide Ligands Are Preferentially Anchored at Their C Termini
Prilliman, K. R., Jackson, K. W., Lindsey, M., Wang, J., Crawford, D., & Hildebrand, W. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7277 · Cited by 56
Identifying HLA supertypes by learning distance functions
Hertz, T., & Yanover, C. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btl324 · Cited by 54
Population of the HLA Ligand Database
Sathiamurthy, M., Hickman, H. D., Cavett, J. W., Zahoor, A. F., Prilliman, K. R., Metcalf, S., Fernández-Viña, M., & Hildebrand, W. H. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.610102.x · Cited by 54
Ressing, M. E., de Jong, J. H., Brandt, R. M. P., Drijfhout, J. W., Benckhuijsen, W. E., Schreuder, G. M. T., Offringa, R., Kast, W. M., & Melief, C. J. M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199904)29:04<1292::aid-immu1292>3.0.co;2-6 · Cited by 54
Brander, C., O’Connor, P. G., Suscovich, T. J., Jones, N. G., Lee, Y. J., Kedes, D. H., Ganem, D., Martin, J. N., Osmond, D. H., Southwood, S., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/322003 · Cited by 53
Self-citationLivingston, B. D., Crimi, C., Fikes, J. D., Chesnut, R. W., Sidney, J., & Sette, A. (1999) · Human Immunology · doi:10.1016/s0198-8859(99)00103-2 · Cited by 51
Self-citationBurrows, S. R., Elkington, R., Miles, J. J., Green, K. J., Walker, S., Haryana, S. M., Moss, D. J., Dunckley, H., Burrows, J. M., & Khanna, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1407 · Cited by 50
Human Leukocyte Antigen Class I Supertypes Influence Susceptibility and Severity of Tuberculosis
Balamurugan, A., Sharma, S. K., & Mehra, N. K. (2004) · The Journal of Infectious Diseases · doi:10.1086/381689 · Cited by 49
Simultaneous Prediction of Binding Capacity for Multiple Molecules of the HLA B44 Supertype
Sidney, J., Southwood, S., Pasquetto, V., & Sette, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5964 · Cited by 49
Self-citationFIMM, a database of functional molecular immunology: update 2002
Schönbach, C., Koh, J. L. Y., Flower, D. R., Wong, L., & Brusic, V. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.226 · Cited by 48
Matsueda, S., Takedatsu, H., Yao, A., Tanaka, M., Noguchi, M., Itoh, K., & Harada, M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0682 · Cited by 45
Sidney, J., Southwood, S., & Sette, A. (2005) · Immunogenetics · doi:10.1007/s00251-005-0004-2 · Cited by 45
Self-citationA framework to sub-type HLA supertypes
Kangueane, P. (2005) · Frontiers in bioscience · doi:10.2741/1582 · Cited by 44
HLA-A3 supermotif defined by quantitative structure–activity relationship analysis
Guan, P., Doytchinova, I. A., & Flower, D. R. (2003) · Protein Engineering Design and Selection · doi:10.1093/proeng/gzg005 · Cited by 43
Hogan, K. T., Sutton, J. N., Chu, K. U., Busby, J., Shabanowitz, J., Hunt, D. F., & Slingluff, C. L. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0592-y · Cited by 42
Bihl, F. K., Narayan, M., Chisholm, J. V., Henry, L. M., Suscovich, T. J., Brown, E. E., Welzel, T. M., Kaufmann, D., Zaman, T., Dollard, S. C., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02509-06 · Cited by 42
Self-citationAltfeld, M. A., Allen, T. M., Kalife, E. T., Frahm, N., Addo, M. M., Mothé, B. R., Rathod, A., Reyor, L. L., Harlow, J., Yu, X. G., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5000-5005.2005 · Cited by 40
Self-citationSette, A., Sidney, J., Livingston, B. D., Dzuris, J. L., Crimi, C., Walker, C. M., Southwood, S., Collins, E. J., & Hughes, A. L. (2003) · Immunogenetics · doi:10.1007/s00251-002-0530-0 · Cited by 39
Self-citationImproving MHC binding peptide prediction by incorporating binding data of auxiliary MHC molecules
Zhu, S., Udaka, K., Sidney, J., Sette, A., Aoki-Kinoshita, K. F., & Mamitsuka, H. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl141 · Cited by 39
Self-citationThe HLA-A0207 Peptide Binding Repertoire is Limited to a Subset of the A0201 Repertoire
Sidney, J., del Guercio, M., Southwood, S., Hermanson, G., Maewal, A., Appella, E., & Sette, A. (1997) · Human Immunology · doi:10.1016/s0198-8859(97)00206-1 · Cited by 37
Self-citationDesign of multi-epitope, analogue-based cancer vaccines
Fikes, J. D., & Sette, A. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.6.985 · Cited by 36
Self-citationDoytchinova, I. A., & Flower, D. R. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b300707c · Cited by 34
MacDonald, K. S., Matukas, L. M., Embree, J. E., Fowke, K. R., Kimani, J., Nagelkerke, N. J. D., Oyugi, J. O., Kiama, P., Kaul, R., Luscher, M. A., et al. (2001) · Immunology Letters · doi:10.1016/s0165-2478(01)00277-2 · Cited by 32
Apostolopoulos, V., Yu, M., Corper, A. L., Li, W., McKenzie, I. F. C., Teyton, L., Wilson, I. A., & Plebanski, M. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00198-5 · Cited by 31
Takedatsu, H., Shichijo, S., Katagiri, K., Sawamizu, H., Sata, M., & Itoh, K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0797-3 · Cited by 31
Minami, T., Matsueda, S., Takedatsu, H., Tanaka, M., Noguchi, M., Uemura, H., Itoh, K., & Harada, M. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0216-9 · Cited by 31
Zhang, H., Pang, X., Shang, X., Xing, Q., & Chen, W. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00102.x · Cited by 30
Structural Definition of the H-2Kd Peptide-binding Motif
Mitaksov, V., & Fremont, D. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510511200 · Cited by 30
Lyke, K. E., Burges, R., Cissoko, Y., Sangaré, L., Kone, A. K., Dao, M., Diarra, I., Fernández-Viña, M., Plowe, C. V., Doumbo, O. K., et al. (2005) · Infection and Immunity · doi:10.1128/iai.73.9.5799-5808.2005 · Cited by 28
Compression of functional space in HLA-A sequence diversity
Zhao, B., PNG, A. E. H., Ren, E. C., Kolatkar, P. R., Mathura, V. S., Sakharkar, M. K., & Kangueane, P. (2003) · Human Immunology · doi:10.1016/s0198-8859(03)00078-8 · Cited by 27
Ma, L., Moan, J. E., Peng, Q., & Iani, V. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981109)78:4<518::aid-ijc20>3.0.co;2-0 · Cited by 27
Lichterfeld, M. D., Williams, K. L., Mui, S. K., Shah, S. S., Mothé, B. R., Sette, A., Kim, A. Y., Johnston, M. N., Burgett, N., Frahm, N., et al. (2006) · International Immunology · doi:10.1093/intimm/dxl052 · Cited by 25
Self-citationThe immune epitope database and analysis resource: from vision to blueprint.
Sette, A. (2004) · PubMed · Cited by 23
Self-citationA geometric study of the amino acid sequence of class I HLA molecules
Cano, P., Fan, B., & Stass, S. A. (1998) · Immunogenetics · doi:10.1007/s002510050439 · Cited by 23
HLA-A2-Restricted Protection against Lethal Lymphocytic Choriomeningitis
Botten, J., Whitton, J. L., Barrowman, P., Sidney, J., Whitmire, J. K., Alexander, J., Ting, J. P., Bui, H., Sette, A., & Buchmeier, M. J. (2006) · Journal of Virology · doi:10.1128/jvi.02063-06 · Cited by 21
Self-citationHoneyborne, I., Rathod, A., Buchli, R., Ramduth, D., Moodley, E. S., Rathnavalu, P., Chetty, S., Day, C. L., Brander, C., Hildebrand, W. H., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.8.4699 · Cited by 20
Self-citationGorga, J. C., Madden, D. R., Prendergast, J. K., Wiley, D. C., & Strominger, J. L. (1992) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340120110 · Cited by 19
Guan, P., Doytchinova, I. A., & Flower, D. R. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00109-3 · Cited by 18
New Peptide Vaccine Candidates for Epithelial Cancer Patients With HLA-A3 Supertype Alleles
Matsueda, S., Takedatsu, H., Sasada, T., Azuma, K., Ishihara, Y., Komohara, Y., Noguchi, M., Shichijo, S., Itoh, K., & Harada, M. (2007) · Journal of Immunotherapy · doi:10.1097/01.cji.0000211340.88835.e7 · Cited by 15
Ostrout, N. D., MCHUGH, M. M., Tisch, D. J., Moormann, A. M., Brusić, V., & Kazura, J. W. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03401.x · Cited by 14
Peptides control the gain and loss of allele specificity by mutated MHC class I molecules.
Hengel, H., Burke, K. L., Kyburz, D., Zinkernagel, R. M., & Koszinowski, U. H. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4557 · Cited by 7
Cross‐Binding BetweenPlasmodium falciparumCTL Epitopes and HLA Class I Molecules
Tang, Y., Lin, Y., Mao, Y., Dong, M., & Wang, H. (2003) · Immunological Investigations · doi:10.1081/imm-120019206 · Cited by 2
Cited by
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
Self-citationPan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
Cristescu, R., Mogg, R., Ayers, M., Albright, A., Murphy, E., Yearley, J., Sher, X., Liu, X. Q., Lu, H., Nebozhyn, M., et al. (2018) · Science · doi:10.1126/science.aar3593 · Cited by 2,301
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Havel, J. J., Chowell, D., & Chan, T. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0116-x · Cited by 2,286
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Chowell, D., Morris, L. G. T., Grigg, C. M., Weber, J. K., Samstein, R. M., Makarov, V., Kuo, F., Kendall, S. M., Requena, D., Riaz, N., et al. (2018) · Science · doi:10.1126/science.aao4572 · Cited by 1,142
Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level
Wu, Y., Yang, S., Ma, J., Chen, Z., Song, G., Rao, D., Cheng, Y., Huang, S., Liu, Y., Jiang, S., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0316 · Cited by 1,139
Metadata
- Authors
- Sidney, J., Peters, B., Frahm, N., Brander, C., & Sette, A.
- Affiliations
- La Jolla Institute for Immunology (US)
- Harvard University (US)
- Corresponding author
- Sette, Alessandro
- Venue
- BMC Immunology
- Published
- 2008-01-22
- Volume
- 9
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1471-2172 (ISSN-L)
- PMC
- PMC2245908
- OpenAlex
- W2134182833
- Cited by
- 775
- References
- 114
- Citations by year
- 2026: 34 · 2025: 49 · 2024: 35 · 2023: 67 · 2022: 48 · 2021: 79 · 2020: 82 · 2019: 36 · 2018: 31 · 2017: 32 · 2016: 36 · 2015: 36 · 2014: 30 · 2013: 34 · 2012: 35
- FWCI
- 15.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- BMC Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (HHSN266200400006C, n01ai40023-7-0-1, n01ai40024-7-0-1)
- National Institute of Allergy and Infectious Diseases (N01 AI040024, N01-AI-40024, N01 AI040023)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- HLA supertypes, HLA-A alleles, HLA-B alleles, MHC class I, peptide binding specificity, epitope identification, vaccine design, HLA polymorphism, antigen presentation
- MeSH terms
- Alleles, Epitopes, Binding Sites, Histocompatibility Testing, Humans, Protein Binding, Histocompatibility Antigens Class I, Immunodominant Epitopes, Antigen Presentation, Sequence Analysis, Protein, Amino Acid Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.